Diabetes and prediabetes affects almost half of the U.S. adult population. Increasing evidence shows that diabetes adversely affects women more than men despite higher prevalence in men. Several studies have reported that telemedicine can improve diabetes management through better metabolic and glycemic control. Little is known about how gender mediates the clinical outcomes of telemedicine for post-discharge diabetes management. To address this gap, Dr. Michaud and colleagues from the University of Nebraska Medical Center College of Public Health conducted a study, published in the January issue of Diabetes Research and Clinical Practice.
Based on data from an remote patient monitory program (RPM) that enrolled post-discharge type 2 diabetes (n = 1645) in 2014–2017, the authors assessed the gender difference in the likelihood of completing the three-month RPM program and the gender difference in post-RPM hemoglobin A1c (HbA1c), controlling for demographics, baseline health status, including HbA1c, patient activation scores, and physiological data upload frequency for patients who had completed the program.
The results showed that men had lower odds of completing the three-month RPM program than women. However, among those who completed the program, men had lower post-RPM HbA1c than women after controlling for baseline HbA1c and other covariates. The authors concluded that “while female patients with type 2 diabetes were more likely to complete the RPM program, they showed a higher glycemic level at the end of the program compared to male patients. To close gender disparities in health, interventions through telemedicine tailored towards women’s diabetes outcomes and men’s engagement level are warranted.”Friday Letter Submission, Publish on January 10